News
Banks are seeing NPLs decline, with further relief expected as credit growth picks up and Resolution 42 is formalised to ...
Following execution of the licence agreement, GEIH and A*STAR will begin the next phase of scaling up to accelerate the ...
The Vexev and U.S. Renal Care teams successfully completed enrollment in the CANSCAN trial. The study is evaluating the use ...
WAIC 2025 centred around the theme of "Global Solidarity in the AI Era". The conference brought together global experts, ...
The issuer is solely responsible for the content of this announcement.
BBM tests with ≥90% sensitivity and ≥75% specificity can be used as a triaging test, in which a negative result rules out ...
EQT announced today that BPEA Private Equity Fund IX ("EQT") intends to make a USD 2.7 billion tender offer ("Tender Offer") ...
China's AI ambitions take center stage as Suzhou becomes a hub of smart tech. More than 20 high-profile product launches were ...
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 30, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results